Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osteogenon for Fracture Healing
NCT07210281Phase 4Recruiting
- Sponsor
- University of Opole
- Start
- Nov 2024
- Primary completion
- Feb 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Osteogenon in bone fracture (Fx), sponsored by University of Opole. Started Nov 2024; status: recruiting.
02
Drugs
Osteogenon
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on NCT07210281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07210281.